Hormone Disorder Treatment Market

Published Nov 23 

Hemant Borikar
By Hemant Borikar

9 Articles

Global Growth Hormone Disorder Treatment Market Growth Globally at rate of CAGR of 4.67% forecast period 2023 to 2030.

Growth Hormone Disorder Treatment Market Scope and Size

Market Definition

Growth hormone disorder is a rare type of condition that is typically characterized by inadequate secretion of growth hormone (GH) from the anterior pituitary gland. This kind of hormones can be present since birth and cause serious genetic mutation or structural defects in the brain. The growth hormone disorders can be acquired in the later years due to the presence of severe infection, trauma among others. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy.

Market Segmentation

Type (Acquired GHD, Congenital GHD, Idiopathic GHD, Others), Disorders (Small for Gestational Age (SGA), Short Stature, Idiopathic Short Stature, Turner Syndrome, Noonan Syndrome, Prader-Willi Syndrome, Laron Syndrome, Gigantism & Acromegaly, Others), Treatment (Diagnosis, Treatment, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Market Scope

The global growth hormone disorder treatment market is segmented on the basis of type, disorders, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


ü Acquired GHD

ü Congenital GHD

ü Idiopathic GHD


ü Small for Gestational Age (SGA)

ü Short Stature

ü Idiopathic Short Stature

ü Turner Syndrome

End User

ü Hospitals

ü Homecare

Distribution Channel

ü Hospital Pharmacy

ü Online Pharmacy

Get the sample copy of Report here:

Market Analysis and Insights - Growth Hormone Disorder Treatment Market

· North America has been witnessing a positive growth for global growth hormone disorder treatment market throughout the forecast period due to the region's increased R&D activities on growth hormones and well-established health care infrastructure.

· The major countries covered in the global growth hormone disorder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

· Asia-Pacific dominates the market due to increased technological advancement and the increasing prevalence of chronic and metabolic diseases.

Growth Hormone Disorder Treatment Market

Country Level Analysis

The global growth hormone disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global growth hormone disorder treatment market

Key Players Growth Hormone Disorder Treatment

· Teva Pharmaceutical Industries Ltd (Israel)

· Amneal Pharmaceutical Inc (U.S.)

· Mayne Pharma Group Limited (Australia)

· Merck KGaA (Germany)

· Sanofi (France)

· Sun Pharmaceutical Industries Ltd. (India)

· Novartis AG (Switzerland)

· F. Hoffmann-La Roche Ltd (Switzerland)

· Abbott (U.S.)

· PT. Daewoong Pharmaceutical Company (South Korea)

· Genentech, Inc (U.S.)

· Bausch Health Companies Inc. (Canada)

· Lilly (U.S.)

· Ipsen Pharma (France)

· Ferring B.V. (Switzerland)

Get Full Access of Report @


· Chapter One: Introduction

· Chapter Two: Market Segmentation

· Chapter Three: Market Overview

· Chapter Four: Executive Summary

· Chapter Five: Premium Insights

· Chapter Six: Global OEMS Market by Product & Procedure type

Get TOC Details:

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.


Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com